Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02916069
Other study ID # IRB00008715621
Secondary ID
Status Recruiting
Phase N/A
First received September 16, 2016
Last updated July 5, 2017
Start date September 2016
Est. completion date May 2018

Study information

Verified date July 2017
Source Assiut University
Contact Mohamed Ali, PhD. MD
Phone 0020882413201
Email msali58@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Multimodal brain monitoring is feasible and can be used in formulating therapeutic strategies during cardiac surgery. Such monitoring may help to improve patient outcome and to reduce costs after cardiac surgery with CPB.


Description:

The aim of this study is to use a combination of brain monitoring {Nearinfrared Spectroscopy (NIRS), Transcranial Doppler (TCD), bispectral index (BIS)} to formulate therapeutic strategies based on these monitors and to evaluate the impact on patient outcome.


Recruitment information / eligibility

Status Recruiting
Enrollment 1200
Est. completion date May 2018
Est. primary completion date March 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Elective cardiac surgery with cardiopulmonary bypass

- Valve replacement

- Coronary artery bypass

Exclusion Criteria:

- Emergency surgery

- Hepatic

- Renal impairment

- Diabetes Mellitus

Study Design


Related Conditions & MeSH terms

  • Intraoperative Neurophysiological Monitoring

Intervention

Device:
Nearinfrared Spectroscopy (NIRS)
Patients will be monitored and interference will be done to optimize the medical condition based on such monitor
Transcranial Doppler (TCD)
Patients will be monitored and interference will be done to optimize the medical condition based on such monitor
Bispectral index (BIS)
Patients will be monitored and interference will be done to optimize the medical condition based on such monitor

Locations

Country Name City State
Egypt Faculty of medicine Assiut University Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary S100 protein S100 protein (marker of brain injury) up to 24 hours
Secondary Mini-mental state examination up to 30 days after surgery
Secondary Western perioperative neurological scale up to 30 days after surgery
Secondary Major neurological out come as stoke up to 30 days after surgery
Secondary Duration of mechanical ventilation up to 30 days after surgery
Secondary Hospital stay up to 30 days after surgery
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03691103 - Record and Analyze the Data of Patient Undergoing Anesthesia for Laparoscopic Cholecystectomy From Patient Monitoring Instruments
Not yet recruiting NCT03688529 - Analyzing the Noxious Autonomic Response During Shoulder Arthroscope Surgery
Recruiting NCT02592915 - Effect of a Bolus of Clonidine Systemically Administered on the Excitability of the Spinal Motoneurons of the Lower Extremity Phase 3
Active, not recruiting NCT04443465 - Patient Experiences of IONM and Outcomes
Recruiting NCT04938765 - Effect of Magnesium Sulfate Bolus on Intraoperative Neuromonitoring Phase 4
Recruiting NCT02305576 - Effect of Perioperative Factors on the Analgesia Nociception Index